Core Viewpoint - Envoy Medical, Inc. is set to present a corporate overview at the LD Micro Main Event XVII, highlighting its focus on fully implanted hearing systems and innovative products in the hearing health sector [1][2]. Company Overview - Envoy Medical specializes in hearing health, particularly in fully implanted hearing systems, with products like the Esteem fully implanted active middle ear implant (FI-AMEI) and the Acclaim Cochlear Implant [1][5]. - The Esteem FI-AMEI is the only FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss, providing continuous hearing without the need for external components [3]. - The Acclaim Cochlear Implant is an investigational device designed for severe to profound sensorineural hearing loss, leveraging the ear's natural anatomy for sound capture [5]. Product Details - The Esteem FI-AMEI offers 24/7 hearing capability, is invisible, and does not require external components or cleaning, distinguishing it from traditional hearing aids [3]. - The Acclaim Cochlear Implant received Breakthrough Device Designation from the FDA in 2019, marking it as a significant advancement in hearing technology [5]. Event Information - David R. Wells, the Chief Financial Officer, will present on October 29, 2024, at 12:00 PM Pacific Time, and will be available for one-on-one meetings with registered investors [2][3].
Envoy Medical to Present at the LD Micro Main Event XVII